Publicaciones en las que colabora con Javier Zulueta Frances (47)

2024

  1. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  2. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

    Journal of Thoracic Oncology, Vol. 19, Núm. 3, pp. 476-490

  3. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

2022

  1. New or enlarging hiatal hernias after thoracic surgery for early lung cancer

    JTCVS Open, Vol. 10, pp. 415-423

2021

  1. A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer

    Translational Research, Vol. 233, pp. 77-91

  2. Diagnostic accuracy of visual analysis versus dual time-point imaging with 18F-FDG PET/CT for the characterization of indeterminate pulmonary nodules with low uptake

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 3, pp. 155-160

  3. Molecular biomarkers in early stage lung cancer

    Translational Lung Cancer Research, Vol. 10, Núm. 2, pp. 1165-1185

  4. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD

    Clinical Imaging, Vol. 78, pp. 136-141

2020

  1. Avances en el manejo del cáncer de pulmón

    Anales del sistema sanitario de Navarra, Vol. 43, Núm. 2, pp. 131-139

  2. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: Preliminary experience from a series of 10 Spanish patients

    Thorax, Vol. 75, Núm. 12, pp. 1116-1118

2019

  1. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

    Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357

  2. CT screening for lung cancer: comparison of three baseline screening protocols

    European Radiology, Vol. 29, Núm. 10, pp. 5217-5226

  3. Survival with Parenchymal and Pleural Invasion of Non–Small Cell Lung Cancers Less than 30 mm

    Journal of Thoracic Oncology, Vol. 14, Núm. 5, pp. 890-902

2018

  1. Baseline and annual repeat rounds of screening: implications for optimal regimens of screening

    European Radiology, Vol. 28, Núm. 3, pp. 1085-1094

2017

  1. Telomere length, COPD and emphysema as risk factors for lung cancer

    European Respiratory Journal

2016

  1. A novel epigenetic signature for early diagnosis in lung cancer

    Clinical Cancer Research, Vol. 22, Núm. 13, pp. 3361-3371

  2. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

    Lung Cancer, Vol. 97, pp. 81-86

  3. Impact of surgery for stage IA non-smallcell lung cancer on patient quality of life

    Journal of Community and Supportive Oncology, Vol. 14, Núm. 1, pp. 37-44

2015

  1. Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer

    PLoS ONE, Vol. 10, Núm. 3